According to the data in The Cancer Genome Atlas (TCGA), KRAS mutations most often occur in endoderm-derived tumours such as pancreatic carcinoma, genomically stable colorectal cancer and lung adenocarcinoma. Here, KRAS is linked to colorectal cancer.